[Why antiretroviral therapy must not begin to early?].
Valantin
Marc-Antoine
MA
Service des maladies infectieuses et tropicales, groupe hospitalier La Pitié-La Salpêtrière, 75651 Paris 13.
Katlama
Christine
C
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D018450:Disease Progression; D006017:Glycolipids / Q000378:metabolism; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D039682:HIV-Associated Lipodystrophy Syndrome / Q000209:etiology; D006801:Humans; D028361:Mitochondrial Diseases / Q000139:chemically induced; D013997:Time Factors; D019562:Viral Load
D019380:Anti-HIV Agents; D006017:Glycolipids